Adila Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.01 Cr
as on 17-12-2024
- Paid Up Capital ₹ 0.13 M
as on 17-12-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -43.36%
(FY 2022)
- Profit 5.18%
(FY 2022)
- Ebitda 80.88%
(FY 2022)
- Net Worth 27.06%
(FY 2022)
- Total Assets -20.09%
(FY 2022)
About Adila Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.01 Cr and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Divyansh Agarwal and Anmol Agarwal serve as directors at the Company.
- CIN/LLPIN
U24232RJ2009PTC029650
- Company No.
029650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Adila Biotech Private Limited offer?
Adila Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Ayurvedic Joint Pain Relief Medicine, Herbal Joint Pain Relief Tablets, Antacid Drugs, Antacid Tablets.
Who are the key members and board of directors at Adila Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divyansh Agarwal  | Director | 22-May-2020 | Current |
| Anmol Agarwal | Director | 20-Sep-2019 | Current |
Financial Performance of Adila Biotech.
Adila Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.36% decrease. The company also saw a slight improvement in profitability, with a 5.18% increase in profit. The company's net worth Soared by an impressive increase of 27.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adila Biotech?
Unlock access to Adila Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dayjoy Marketing Private LimitedActive 6 years 3 monthsDivyansh Agarwal and Anmol Agarwal are mutual person
Adila Agrofoods Private LimitedActive 6 years 9 monthsDivyansh Agarwal and Anmol Agarwal are mutual person
- Flywood Impressions Private LimitedActive 5 years 10 months
Divyansh Agarwal and Anmol Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adila Biotech?
Unlock and access historical data on people associated with Adila Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adila Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adila Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
